Cargando…
Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is a hypercoagulable state accompanied by the presence of heterogeneous antiphospholipid antibodies (aPL), which nonspecifically affect hemostasis by the presence of lupus anticoagulans (LA), anticardiolipin antibodies (aCL), antibodies against β2-glycoprotein-I (anti...
Autores principales: | Bradáčová, Pavla, Slavík, Luděk, Skoumalová, Adéla, Úlehlová, Jana, Kriegová, Eva, Manukyan, Gayane, Friedecký, David, Piskláková, Barbora, Ullrychová, Jana, Procházková, Jana, Hluší, Antonín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409152/ https://www.ncbi.nlm.nih.gov/pubmed/36012233 http://dx.doi.org/10.3390/ijms23168973 |
Ejemplares similares
-
Current Promising Biomarkers and Methods in the Diagnostics of Antiphospholipid Syndrome: A Review
por: Bradacova, Pavla, et al.
Publicado: (2021) -
Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
por: Úlehlová, Jana, et al.
Publicado: (2021) -
17β-Estradiol Promotes Proinflammatory and Procoagulatory Phenotype of Innate Immune Cells in the Presence of Antiphospholipid Antibodies
por: Manukyan, Gayane, et al.
Publicado: (2020) -
Anti-domain 1 β2 glycoprotein antibodies increase expression of tissue factor on monocytes and activate NK Cells and CD8+ cells in vitro
por: Manukyan, Gayane, et al.
Publicado: (2020) -
Evaluation of the DOAC-Stop Procedure by LC-MS/MS Assays for Determining the
Residual Activity of Dabigatran, Rivaroxaban, and Apixaban
por: Slavik, L., et al.
Publicado: (2019)